Issue navigation
Volume 7, Issue 1, February 2020
Editorial
Surveys, debate, and contemporary practice: lessons to be learnt to improve neuro-oncology care
Neuro-Oncology Practice, Volume 7, Issue 1, February 2020, Pages 1–2, https://doi.org/10.1093/nop/npz073
Reviewer Acknowledgment
Reviewer List
Neuro-Oncology Practice, Volume 7, Issue 1, February 2020, Page 3, https://doi.org/10.1093/nop/npz074
Reviews
Neuro-Oncology Practice Clinical Debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma
Neuro-Oncology Practice, Volume 7, Issue 1, February 2020, Pages 4–10, https://doi.org/10.1093/nop/npz033
Cognitive impairment after cytotoxic chemotherapy
Neuro-Oncology Practice, Volume 7, Issue 1, February 2020, Pages 11–21, https://doi.org/10.1093/nop/npz052
Original Articles
Ongoing improvements in postoperative survival of glioblastoma in the temozolomide era: a population-based data linkage study
Neuro-Oncology Practice, Volume 7, Issue 1, February 2020, Pages 22–30, https://doi.org/10.1093/nop/npz021
Driving innovation through collaboration: development of clinical annotation datasets for brain cancer biobanking
Neuro-Oncology Practice, Volume 7, Issue 1, February 2020, Pages 31–37, https://doi.org/10.1093/nop/npz036
Provider-reported challenges and barriers to referring patients to neuro-oncology clinical trials: a report from the Society for Neuro-Oncology member survey
Neuro-Oncology Practice, Volume 7, Issue 1, February 2020, Pages 38–51, https://doi.org/10.1093/nop/npz038
Patterns of bevacizumab use in patients with glioblastoma: an online survey among experts in neuro-oncology
Neuro-Oncology Practice, Volume 7, Issue 1, February 2020, Pages 52–58, https://doi.org/10.1093/nop/npz022
Evaluation of patient education materials for stereotactic radiosurgery from high-performing neurosurgery hospitals and professional societies
Neuro-Oncology Practice, Volume 7, Issue 1, February 2020, Pages 59–67, https://doi.org/10.1093/nop/npz031
Do we really know who has an MGMT methylated glioma? Results of an international survey regarding use of MGMT analyses for glioma
Neuro-Oncology Practice, Volume 7, Issue 1, February 2020, Pages 68–76, https://doi.org/10.1093/nop/npz039
Prevalence and correlates of fatigue in patients with meningioma before and after surgery
Neuro-Oncology Practice, Volume 7, Issue 1, February 2020, Pages 77–85, https://doi.org/10.1093/nop/npz023
Impact of volume of irradiation on survival and quality of life in glioblastoma: a prospective, phase 2, randomized comparison of RTOG and MDACC protocols
Neuro-Oncology Practice, Volume 7, Issue 1, February 2020, Pages 86–93, https://doi.org/10.1093/nop/npz024
Salvage craniotomy for treatment-refractory symptomatic cerebral radiation necrosis
Neuro-Oncology Practice, Volume 7, Issue 1, February 2020, Pages 94–102, https://doi.org/10.1093/nop/npz028
Mapping the nature of distress raised by patients with high-grade glioma and their family caregivers: a descriptive longitudinal study
Neuro-Oncology Practice, Volume 7, Issue 1, February 2020, Pages 103–110, https://doi.org/10.1093/nop/npz032
Temozolomide radiochemotherapy for high-grade glioma patients with hemodialysis: a case series of 7 patients
Neuro-Oncology Practice, Volume 7, Issue 1, February 2020, Pages 111–117, https://doi.org/10.1093/nop/npz034
Leptomeningeal dissemination of low-grade neuroepithelial CNS tumors in adults: a 15-year experience
Neuro-Oncology Practice, Volume 7, Issue 1, February 2020, Pages 118–126, https://doi.org/10.1093/nop/npz020
Society News
Forthcoming Meetings in 2020
Neuro-Oncology Practice, Volume 7, Issue 1, February 2020, Page 127, https://doi.org/10.1093/nop/npz075
